You are here

Stanley Center for Psychiatric Research

Schecter RW, Maher EE, Welsh CA, Stevens B, Erisir A, Bear MF. Experience-Dependent Synaptic Plasticity in V1 Occurs without Microglial CX3CR1. J Neurosci. 2017;37(44):10541-10553. doi:10.1523/JNEUROSCI.2679-16.2017.
Ofengeim D, Mazzitelli S, Ito Y, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer's disease. Proc Natl Acad Sci U S A. 2017;114(41):E8788-E8797. doi:10.1073/pnas.1714175114.
Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23(9):1018-1027. doi:10.1038/nm.4397.
Platt RJ, Zhou Y, Slaymaker IM, et al. Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. Cell Rep. 2017;19(2):335-350. doi:10.1016/j.celrep.2017.03.052.
Campbell JN, Macosko EZ, Fenselau H, et al. A molecular census of arcuate hypothalamus and median eminence cell types. Nat Neurosci. 2017;20(3):484-496. doi:10.1038/nn.4495.
Arlotta P, Vanderhaeghen P. Editorial overview: Developmental neuroscience 2017. Curr Opin Neurobiol. 2017;42:A1-A4. doi:10.1016/j.conb.2017.01.003.
Ahfeldt T, Litterman NK, Rubin LL. Studying human disease using human neurons. Brain Res. 2017;1656:40-48. doi:10.1016/j.brainres.2016.03.051.
Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481-487. doi:10.1038/nature21029.
Greene JS, Brown M, Dobosiewicz M, et al. Balancing selection shapes density-dependent foraging behaviour. Nature. 2016;539(7628):254-258. doi:10.1038/nature19848.
Hyman SE, Landis SC, Leshner AI. Research Into Brain Disorders as an Example of Targeted Science. JAMA. 2016;316(16):1673-1674. doi:10.1001/jama.2016.12412.
Andrade A, Hope J, Allen A, Yorgan V, Lipscombe D, Pan JQ. A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity. Sci Rep. 2016;6:34233. doi:10.1038/srep34233.
Coleman JJ, Komura T, Munro J, et al. Activity of caffeic acid phenethyl ester in Caenorhabditis elegans. Future Med Chem. 2016. doi:10.4155/fmc-2016-0085.
Herring A, Messana A, Bara AM, Hazelbaker DZ, Eggan K, Barrett LE. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):430-432. doi:10.1016/j.scr.2016.09.009.
Bara AM, Messana A, Herring A, Hazelbaker DZ, Eggan K, Barrett LE. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):441-443. doi:10.1016/j.scr.2016.09.008.
Loh KH, Stawski PS, Draycott AS, et al. Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts. Cell. 2016;166(5):1295-1307.e21. doi:10.1016/j.cell.2016.07.041.
Hong S, Stevens B. Microglia: Phagocytosing to Clear, Sculpt, and Eliminate. Dev Cell. 2016;38(2):126-8. doi:10.1016/j.devcel.2016.07.006.
Matranga CB, Gladden-Young A, Qu J, et al. Unbiased Deep Sequencing of RNA Viruses from Clinical Samples. J Vis Exp. 2016;(113). doi:10.3791/54117.
Goes FS, Pirooznia M, Parla JS, et al. Exome Sequencing of Familial Bipolar Disorder. JAMA Psychiatry. 2016;73(6):590-7. doi:10.1001/jamapsychiatry.2016.0251.
Berglund K, Wen L, Dunbar RL, Feng G, Augustine GJ. Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers. J Neurosci. 2016;36(21):5709-23. doi:10.1523/JNEUROSCI.4366-15.2016.
Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712-716. doi:10.1126/science.aad8373.
Wells MF, Wimmer RD, L Schmitt I, Feng G, Halassa MM. Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice. Nature. 2016;532(7597):58-63. doi:10.1038/nature17427.
Quadrato G, Zhang AC, Arlotta P. Stressed out? Healing Tips for Newly Reprogrammed Neurons. Cell Stem Cell. 2016;18(3):297-9. doi:10.1016/j.stem.2016.02.008.
Stevens B, Muthukumar AK. Cellular neuroscience. Differences among astrocytes. Science. 2016;351(6275):813. doi:10.1126/science.aaf2849.
Zhang Q, Gao X, Li C, et al. Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice. J Neurosci. 2016;36(7):2247-60. doi:10.1523/JNEUROSCI.2528-15.2016.
Sekar A, Bialas AR, de Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177-83. doi:10.1038/nature16549.
Hong S, Dissing-Olesen L, Stevens B. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol. 2016;36:128-34. doi:10.1016/j.conb.2015.12.004.
Tomassy GSrubek, Dershowitz LBowe, Arlotta P. Diversity Matters: A Revised Guide to Myelination. Trends Cell Biol. 2016;26(2):135-147. doi:10.1016/j.tcb.2015.09.002.
Chen H-H, Arlotta P. Seq-ing the cortex one neuron at a time. Nat Neurosci. 2016;19(2):179-81. doi:10.1038/nn.4230.
Mintzopoulos D, Gillis TE, Robertson HR, et al. Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1(1):39-48. doi:10.1016/j.bpsc.2015.10.001.
Monteiro P, Feng G. Learning From Animal Models of Obsessive-Compulsive Disorder. Biol Psychiatry. 2016;79(1):7-16. doi:10.1016/j.biopsych.2015.04.020.
Brennand KJ, M Marchetto C, Benvenisty N, et al. Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. Stem Cell Reports. 2015;5(6):933-945. doi:10.1016/j.stemcr.2015.10.011.
Lipscombe D, Pan JQ, Schorge S. Tracks through the genome to physiological events. Exp Physiol. 2015;100(12):1429-40. doi:10.1113/EP085129.
Arlotta P, Hobert O. Homeotic Transformations of Neuronal Cell Identities. Trends Neurosci. 2015;38(12):751-62. doi:10.1016/j.tins.2015.10.005.
Chung W-S, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive impairment in disease?. Nat Neurosci. 2015;18(11):1539-1545. doi:10.1038/nn.4142.
Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B. Microglia: Dynamic Mediators of Synapse Development and Plasticity. Trends Immunol. 2015;36(10):605-13. doi:10.1016/j.it.2015.08.008.
Shi Q, Colodner KJ, Matousek SB, et al. Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J Neurosci. 2015;35(38):13029-42. doi:10.1523/JNEUROSCI.1698-15.2015.
Andersen KG, B Shapiro J, Matranga CB, et al. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 2015;162(4):738-50. doi:10.1016/j.cell.2015.07.020.
Schafer DP, Stevens B. Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2015;7(10):a020545. doi:10.1101/cshperspect.a020545.
Schwarz-Romond T, Kiskinis E, Eggan K. Focus on induced pluripotency and cellular reprogramming. EMBO J. 2015;34(11):1435. doi:10.15252/embj.201591615.
Belmonte JCarlos Izp, Callaway EM, Caddick SJ, et al. Brains, genes, and primates. Neuron. 2015;86(3):617-31. doi:10.1016/j.neuron.2015.03.021.
Bosley KS, Botchan M, Bredenoord AL, et al. CRISPR germline engineering--the community speaks. Nat Biotechnol. 2015;33(5):478-86. doi:10.1038/nbt.3227.
Stremlau MH, Andersen KG, Folarin OA, et al. Discovery of novel rhabdoviruses in the blood of healthy individuals from West Africa. PLoS Negl Trop Dis. 2015;9(3):e0003631. doi:10.1371/journal.pntd.0003631.
Burguière E, Monteiro P, Mallet L, Feng G, Graybiel AM. Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol. 2015;30:59-65. doi:10.1016/j.conb.2014.08.008.
Harris J, Tomassy GSrubek, Arlotta P. Building blocks of the cerebral cortex: from development to the dish. Wiley Interdiscip Rev Dev Biol. 2015;4(5):529-44. doi:10.1002/wdev.192.
Lodato S, Arlotta P. Generating neuronal diversity in the mammalian cerebral cortex. Annu Rev Cell Dev Biol. 2015;31:699-720. doi:10.1146/annurev-cellbio-100814-125353.
A de Boer S, Eggan K. A perspective on stem cell modeling of amyotrophic lateral sclerosis. Cell Cycle. 2015;14(23):3679-88. doi:10.1080/15384101.2015.1093712.
Schlaeger TM, Daheron L, Brickler TR, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2015;33(1):58-63. doi:10.1038/nbt.3070.
W Risher C, Patel S, Kim IHwan, et al. Astrocytes refine cortical connectivity at dendritic spines. Elife. 2014;3. doi:10.7554/eLife.04047.
Koren A, Handsaker RE, Kamitaki N, et al. Genetic variation in human DNA replication timing. Cell. 2014;159(5):1015-1026. doi:10.1016/j.cell.2014.10.025.
Gogolla N, Takesian AE, Feng G, Fagiolini M, Hensch TK. Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron. 2014;83(4):894-905. doi:10.1016/j.neuron.2014.06.033.
A de Boer S, Koszka K, Kiskinis E, Suzuki N, Davis-Dusenbery BN, Eggan K. Genetic validation of a therapeutic target in a mouse model of ALS. Sci Transl Med. 2014;6(248):248ra104. doi:10.1126/scitranslmed.3009351.
Ichida JK, TCW J, Williams LA, et al. Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol. 2014;10(8):632-639. doi:10.1038/nchembio.1552.
Smith ZD, Chan MM, Humm KC, et al. DNA methylation dynamics of the human preimplantation embryo. Nature. 2014;511(7511):611-5. doi:10.1038/nature13581.
Szatkiewicz JP, O'Dushlaine C, Chen G, et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry. 2014;19(7):762-73. doi:10.1038/mp.2014.40.
McCarroll SA, Feng G, Hyman SE. Genome-scale neurogenetics: methodology and meaning. Nat Neurosci. 2014;17(6):756-63. doi:10.1038/nn.3716.
Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506(7487):179-84. doi:10.1038/nature12929.
Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506(7487):185-90. doi:10.1038/nature12975.
Carter AC, Davis-Dusenbery BN, Koszka K, Ichida JK, Eggan K. Nanog-independent reprogramming to iPSCs with canonical factors. Stem Cell Reports. 2014;2(2):119-26. doi:10.1016/j.stemcr.2013.12.010.
Alami NH, Smith RB, Carrasco MA, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536-543. doi:10.1016/j.neuron.2013.12.018.
Davis-Dusenbery BN, Williams LA, Klim JR, Eggan K. How to make spinal motor neurons. Development. 2014;141(3):491-501. doi:10.1242/dev.097410.
Guo ZV, Li N, Huber D, et al. Flow of cortical activity underlying a tactile decision in mice. Neuron. 2014;81(1):179-94. doi:10.1016/j.neuron.2013.10.020.
Valdez G, Heyer MP, Feng G, Sanes JR. The role of muscle microRNAs in repairing the neuromuscular junction. PLoS One. 2014;9(3):e93140. doi:10.1371/journal.pone.0093140.
Barton KM, Archin NM, Keedy KS, et al. Selective HDAC inhibition for the disruption of latent HIV-1 infection. PLoS One. 2014;9(8):e102684. doi:10.1371/journal.pone.0102684.
Wagner FF, Weїwer M, Lewis MC, Holson EB. Small molecule inhibitors of zinc-dependent histone deacetylases. Neurotherapeutics. 2013;10(4):589-604. doi:10.1007/s13311-013-0226-1.
Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat Rev Drug Discov. 2013;12(8):581-94. doi:10.1038/nrd4051.
Wang Y, Zhang Y-L, Hennig K, et al. Class I HDAC imaging using [ (3)H]CI-994 autoradiography. Epigenetics. 2013;8(7):756-64. doi:10.4161/epi.25202.
Olson DE, Wagner FF, Kaya T, et al. Discovery of the first histone deacetylase 6/8 dual inhibitors. J Med Chem. 2013;56(11):4816-20. doi:10.1021/jm400390r.
Liske H, Towne C, Anikeeva P, et al. Optical inhibition of motor nerve and muscle activity in vivo. Muscle Nerve. 2013;47(6):916-21. doi:10.1002/mus.23696.
Frumm SM, Fan ZPeng, Ross KN, et al. Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation. Chem Biol. 2013;20(5):713-25. doi:10.1016/j.chembiol.2013.03.020.
Kumar S, Black SJ, Hultman R, et al. Cortical control of affective networks. J Neurosci. 2013;33(3):1116-29. doi:10.1523/JNEUROSCI.0092-12.2013.
Asrican B, Augustine GJ, Berglund K, et al. Next-generation transgenic mice for optogenetic analysis of neural circuits. Front Neural Circuits. 2013;7:160. doi:10.3389/fncir.2013.00160.
Chen R, Zhang J, Wu Y, et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep. 2012;2(5):1329-39. doi:10.1016/j.celrep.2012.09.030.
Chen Q, Cichon J, Wang W, et al. Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron. 2012;76(2):297-308. doi:10.1016/j.neuron.2012.07.011.
Peça J, Feng G. Cellular and synaptic network defects in autism. Curr Opin Neurobiol. 2012;22(5):866-72. doi:10.1016/j.conb.2012.02.015.
Heyer MP, Pani AK, Smeyne RJ, Kenny PJ, Feng G. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci. 2012;32(32):10887-94. doi:10.1523/JNEUROSCI.1732-12.2012.
Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G, Zhang F. A transcription activator-like effector toolbox for genome engineering. Nat Protoc. 2012;7(1):171-92. doi:10.1038/nprot.2011.431.
W. An F, Germain AR, Bishop J, et al. Discovery of Potent and Highly Selective Inhibitors of GSK3b. Bethesda, MD: National Center for Biotechnology Information (US); 2012. Available at: https://www.ncbi.nlm.nih.gov/books/NBK133436/.
Berglund K, Kuner T, Feng G, Augustine GJ. Imaging synaptic inhibition with the genetically encoded chloride indicator Clomeleon. Cold Spring Harb Protoc. 2011;2011(12):1492-7. doi:10.1101/pdb.prot066985.
Wan Y, Feng G, Calakos N. Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J Neurosci. 2011;31(46):16685-91. doi:10.1523/JNEUROSCI.2533-11.2011.
Peça J, Ting J, Feng G. SnapShot: Autism and the synapse. Cell. 2011;147(3):706, 706.e1. doi:10.1016/j.cell.2011.10.015.
Marder SR, Roth B, Sullivan PF, et al. Advancing drug discovery for schizophrenia. Ann N Y Acad Sci. 2011;1236:30-43. doi:10.1111/j.1749-6632.2011.06216.x.
Peça J, Feng G. Neuroscience: When lights take the circuits out. Nature. 2011;477(7363):165-6. doi:10.1038/477165a.
Hempel CM, Sivula M, Levenson JM, et al. A system for performing high throughput assays of synaptic function. PLoS One. 2011;6(10):e25999. doi:10.1371/journal.pone.0025999.
Akil H, Brenner S, Kandel E, et al. Medicine. The future of psychiatric research: genomes and neural circuits. Science. 2010;327(5973):1580-1. doi:10.1126/science.1188654.
Nyegaard M, Severinsen JE, Als TD, et al. Support of association between BRD1 and both schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):582-591. doi:10.1002/ajmg.b.31023.
Lipscombe D, Pan JQian. Tripping the HCN breaker. Neuron. 2009;62(6):747-50. doi:10.1016/j.neuron.2009.06.003.
Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558-69. doi:10.1038/sj.mp.4002151.
Lichtenstein P, Björk C, Hultman CM, Scolnick E, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006;36(10):1417-25. doi:10.1017/S0033291706008385.
Shoop WL, Xiong Y, Wiltsie J, et al. Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A. 2005;102(22):7958-63. doi:10.1073/pnas.0502159102.